Psychoeducation for bipolar II disorder: An exploratory, 5-year outcome subanalysis

Journal of Affective Disorders

Volumn 112, Issue 1-3, 2009, Pages 30-35

  Colom, F ^a   Vieta, E ^a   Sanchez Moreno J ^a   Goikolea, J M ^a   Popova, E ^a   Bonnin, C M ^a   Scott, J ^b,c  

^a HOSPITAL CLÍNIC   (Spain)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Bipolar II disorder; Psychoeducation; Psychotherapy; Relapse prevention

Indexed keywords

ANTIDEPRESSANT AGENT; LITHIUM; MOOD STABILIZER; TRANQUILIZER;

ADULT; ARTICLE; BIPOLAR II DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FUNCTIONAL STATUS; HOSPITALIZATION; HUMAN; HYPOMANIA; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PRIORITY JOURNAL; PSYCHOEDUCATION; RECURRENT DISEASE;

ADULT; BIPOLAR DISORDER; COMBINED MODALITY THERAPY; CONTROL GROUPS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; LONGITUDINAL STUDIES; PATIENT EDUCATION AS TOPIC; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY, GROUP; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; SINGLE-BLIND METHOD; SOCIAL ADJUSTMENT; TREATMENT OUTCOME;

EID: 56549128148     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2008.03.023     Document Type: Article

References (27)

1. Albert U., Rosso G., Maina G., and Bogetto F. Impact of anxiety disorder comorbidity on quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes. J. Affect. Disord. 105 (2008) 297-303
2. Amsterdam J.D., and Garcia-Espana F. Venlafaxine monotherapy in women with bipolar II and unipolar major depression. J. Affect. Disord. 59 (2000) 225-229
3. Amsterdam J.D., Garcia-Espana F., Fawcett J., Quitkin F.M., Reimherr F.W., Rosenbaum J.F., Schweizer E., and Beasley C. Efficacy and safety of fluoxetine in treating bipolar II major depressive episode. J. Clin. Psychopharmacol. 18 (1998) 435-440
4. Berk M., and Dodd S. Bipolar II disorder: a review. Bipolar Disord. 7 (2005) 11-21
5. Brugue E., Colom F., Sanchez-Moreno J., Cruz N., and Vieta E. Depression subtypes in bipolar I and II disorders. Psychopathology 41 (2008) 111-114
6. Colom F., and Vieta E. Psychoeducation Manual for Bipolar Disorder (2006), Cambridge University Press
7. Colom F., Vieta E., Martinez-Aran A., Reinares M., Goikolea J.M., Benabarre A., Torrent C., Comes M., Corbella B., Parramon G., and Corominas J. A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch. Gen. Psychiatry 60 (2003) 402-407
8. Colom, F., Vieta, E., Sanchez-Moreno, J., Palomino-Otiniano, R., Reinares, M., Goikolea, J.M., Benabarre, A., Martinez-Aran, A., in press. Five-year outcome of a randomized clinical trial on the efficacy of group psychoeducation in stabilized bipolar patients. Br. J. Psychiatry.
9. El Mallakh R., Weisler R.H., Townsend M.H., and Ginsberg L.D. Bipolar II disorder: current and future treatment options. Ann. Clin. Psychiatry 18 (2006) 259-266
10. Greil W., and Kleindienst N. Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified. Int. Clin. Psychopharmacol. 14 (1999) 283-285
11. Hadjipavlou G., Mok H., and Yatham L.N. Pharmacotherapy of bipolar II disorder: a critical review of current evidence. Bipolar Disord. 6 (2004) 14-25
12. Judd L.L., Akiskal H.S., Schettler P.J., Coryell W., Endicott J., Maser J.D., Solomon D.A., Leon A.C., and Keller M.B. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch. Gen. Psychiatry 60 (2003) 261-269
13. Judd L.L., Akiskal H.S., Schettler P.J., Endicott J., Leon A.C., Solomon D.A., Coryell W., Maser J.D., and Keller M.B. Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study. Arch. Gen. Psychiatry 62 (2005) 1322-1330
14. Parker G., Tully L., Olley A., and Hadzi-Pavlovic D. SSRIs as mood stabilizers for bipolar II disorder? A proof of concept study. J. Affect. Disord. 92 (2006) 205-214
15. Ruggero C.J., Chelminski I., Young D., and Zimmerman M. Psychosocial impairment associated with bipolar II disorder. J. Affect. Disord. 104 (2007) 53-60
16. Scott J., and Colom F. Gaps and limitations of psychological interventions for bipolar disorders. Psychother. Psychosom. 77 (2008) 4-11
17. Simon G.E., Bauer M.S., Ludman E.J., Operskalski B.H., and Unutzer J. Mood symptoms, functional impairment, and disability in people with bipolar disorder: specific effects of mania and depression. J. Clin. Psychiatry 68 (2007) 1237-1245
18. Summers M., Papadopoulou K., Bruno S., Cipolotti L., and Ron M.A. Bipolar I and bipolar II disorder: cognition and emotion processing. Psychol. Med. (2006) 1-11
19. Suppes T., Hirschfeld R.M., Vieta E., Raines S., and Paulsson B. Quetiapine for the treatment of bipolar II depression: analysis of data from two randomized, double-blind, placebo-controlled studies. World J. Biol. Psychiatry (2007) 1-14
20. Tondo L., Baldessarini R.J., Hennen J., and Floris G. Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders. Am. J. Psychiatry 155 (1998) 638-645
21. Torrent C., Martinez-Aran A., Daban C., Sanchez-Moreno J., Comes M., Goikolea J.M., Salamero M., and Vieta E. Cognitive impairment in bipolar II disorder. Br. J. Psychiatry 189 (2006) 254-259
22. Vieta E., and Rosa A.R. Evolving trends in the long-term treatment of bipolar disorder. World. J. Biol. Psychiatry 8 (2007) 4-11
23. Vieta E., and Suppes T. Bipolar II disorder: arguments for and against a distinct diagnostic entity. Bipolar Disord. 10 (2008) 163-178
24. Vieta E., Gasto C., Otero A., Nieto E., and Vallejo J. Differential features between bipolar I and bipolar II disorder. Compr. Psychiatry 38 (1997) 98-101
25. Vieta E., Gasto C., Colom F., Reinares M., Martinez-Aran A., Benabarre A., and Akiskal H.S. Role of risperidone in bipolar II: an open 6-month study. J. Affect. Disord. 67 (2001) 213-219
26. Vieta E., Sanchez-Moreno J., Goikolea J.M., Torrent C., Benabarre A., Colom F., Martinez-Aran A., Reinares M., Comes M., and Corbella B. Adjunctive topiramate in bipolar II disorder. World J. Biol. Psychiatry 4 (2003) 172-176
27. Zarate Jr. C.A., Payne J.L., Singh J., Quiroz J.A., Luckenbaugh D.A., Denicoff K.D., Charney D.S., and Manji H.K. Pramipexole for bipolar II depression: a placebo-controlled proof of concept study. Biol. Psychiatry 56 (2004) 54-60